The subgaleal shunt has been used for the temporary bypass of the normal cerebrospinal fluid (CSF) pathways. We retrospectively reviewed all subgaleal shunts placed at the Children’s Hospital, Birmingham, Ala., USA, from 1997 to the present and examined all uses (e.g. indication, length of follow-up) of the subgaleal shunt outside its use for temporary CSF diversion in premature infants with intraventricular hemorrhage and subsequent hydrocephalus. The average length of survival of the primary subgaleal shunt in this population was 32.2 days. We have had good success with subgaleal shunts in children with malignant brain tumors, intraventricular abscesses, chronic truncal wounds, chronic subdural hygromas and meningitis. However, the greatest utility has been in those scenarios in which the peritoneal cavities were not currently, but with time would be, candidates for distal shunt implantation. Examples of these instances are patients with hydrocephalus and necrotizing enterocolitis or hydrocephalus and preoperative abdominal wall pathology such as omphalocele.

Fulmer BB, Grabb PA, Oakes WJ, Mapstone TB: Neonatal ventriculosubgaleal shunts. Neurosurgery 2000;47:80–84.
Aoki N: Subcutaneous absorption of cerebrospinal fluid in an infant with hydrocephalus. J Pediatr Neurosci 1988;4:291–295.
Perret GE, Graf CJ: Subgaleal shunt for temporary ventricle decompression and subdural drainage. J Neurosurg 1997;47:590–595.
Savitz MH: Another look at ventriculosubgaleal shunting procedures. Mt Sinai J Med 1997;64:189–193.
Van Calenbergh F, Goffin J, Casaer P, Plets C: Use of a ventriculosubgaleal shunt in the management of hydrocephalus in children with posterior fossa tumors. Childs Nerv Syst 1996;12:34–37.
Drapkin AJ, Levine ME, Yang WC: Ventriculo-subgaleal shunt: Evaluation by computed tomography. Acta Neurochir (Wien) 1980;55:107–115.
Schmid UD, Seiler RW: Management of obstructive hydrocephalus secondary to posterior fossa tumors by steroids and subcutaneous ventricular catheter reservoir. J Neurosurg 1986;65:649–653.
Steinbok P, Cochrane DD: Ventriculosubgaleal shunt in the management of recurrent ventriculoperitoneal shunt infection. Childs Nerv Syst 1994;10:536–539.
Rickert CH: Abdominal metastases of pediatric brain tumors via ventriculo-peritoneal shunts. Childs Nerv Syst 1998;14:10–14.
Aschoff A, Kremer P, Hashmi B, Kunze S: The scientific history of hydrocephalus and its treatment. Neurosurg Rev 1999;22:67–93.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.